2002
Novel and Potent Anti-malarial Agents
Brinner KM, Kim J, Habashita H, Gluzman IY, Goldberg DE, Ellman JA. Novel and Potent Anti-malarial Agents. Bioorganic & Medicinal Chemistry 2002, 10: 3649-3661. PMID: 12213481, DOI: 10.1016/s0968-0896(02)00207-9.Peer-Reviewed Original ResearchConceptsChloroquine-resistant strainsAnti-malarial agentsPlasmodium falciparumAnti-malarial compoundsIC50 valuesInitial lead structuresPotent anti-malarial agentsInterference with Heme Binding to Histidine-Rich Protein-2 as an Antimalarial Strategy
Choi CY, Schneider EL, Kim JM, Gluzman IY, Goldberg DE, Ellman JA, Marletta MA. Interference with Heme Binding to Histidine-Rich Protein-2 as an Antimalarial Strategy. Cell Chemical Biology 2002, 9: 881-889. PMID: 12204687, DOI: 10.1016/s1074-5521(02)00183-7.Peer-Reviewed Original Research
2001
In vitro susceptibility of 232 isolates of Plasmodium falciparum to antimalarials in Burkina Faso (West Africa).
Tinto H, Ouedraogo J, Traoré B, Coulibaly S, Guiguemde T. In vitro susceptibility of 232 isolates of Plasmodium falciparum to antimalarials in Burkina Faso (West Africa). Bulletin De La Société De Pathologie Exotique 2001, 94: 188-91. PMID: 16579075.Peer-Reviewed Original ResearchConceptsP. falciparumPlasmodium falciparumCells/mm3Chloroquine-resistant strainsInclusion criteriaReference centerParasite countsSingle infectionResistant isolatesSignificant positive correlationParasite growthPersistence of resistanceFalciparumHalofantrineBobo-DioulassoSignificant increaseMefloquineIC50 valuesPositive correlationIsolatesQuinineSusceptibilityPatientsBurkina FasoIncubation period
1992
Malaria prophylaxis: taking aim at constantly moving targets.
Bia F. Malaria prophylaxis: taking aim at constantly moving targets. The Yale Journal Of Biology And Medicine 1992, 65: 329-36. PMID: 1290274, PMCID: PMC2589577.Peer-Reviewed Original ResearchConceptsMalaria infectionPlasmodium vivax resistanceChloroquine-resistant strainsVivax resistancePatient populationAdjunctive measuresCertain antimalarialsNumber of womenChemoprophylaxisPalatable formulationsMalaria riskPlasmodium falciparumInfectionPreventionContinued emergenceChildrenToxicityDifferent toxicitiesPotential implicationsGeographic regionsPregnancyRepellent formulationsCliniciansAntimalarialsFalciparum
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply